https://ansm.sante.fr/informations-de-securite/defitelio-defibrotide-v-a-ne-pas-utiliser-en-prophylaxie-de-la-maladie-veino-occlusive-mvo-apres-une-transplantation-de-cellules-souches-hematopoietiques-tcsh 2022 false false false France French hematopoietic stem cell transplantation pharmacovigilance note defibrotide infusions, intravenous defibrotide survival hepatic veno-occlusive disease treatment outcome medical futility
--- https://www.has-sante.fr/jcms/p_3289340/fr/defitelio-80-mg/ml-defibrotide 2021 false false false France evaluation of the transparency committee defibrotide defibrotide defibrotide Defitelio
--- Summary Basis of Decision (SBD) for Defitelio (defibrotide sodium) https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00364 2017 false false false Canada French English drug information defibrotide defibrotide malabsorption syndromes defibrotide myelodysplastic syndromes polydeoxyribonucleotides polydeoxyribonucleotides
--- http://www.has-sante.fr/portail/jcms/c_1756835/fr/defitelio 2014 false false false France French evaluation of the transparency committee defibrotide defibrotide defibrotide hepatic veno-occlusive disease adult adolescent child infant hematopoietic stem cell transplantation treatment outcome orphan drug production infusions, intravenous clinical trials, phase iii as topic survival analysis guidelines for drug use polydeoxyribonucleotides polydeoxyribonucleotides